Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

News

TESLARATI Tweet: Tesla FSD Beta 10.1 would be capable of reversing maneuvers

https://twitter.com/Teslarati/status/1437329097672302593

byCharles Gross

September 13, 2021

1 minute read

Tesla FSD Beta 10.1 would be capable of reversing maneuvershttps://t.co/scmYVqu6Wh by @Writer_01001101

— TESLARATI (@Teslarati) September 13, 2021

Jim Cramer Cheers Twitter, CFO Ned Segal Following Earnings

By Adam Eckert

July 23, 11:25 AM

Twitter Inc (NYSE: TWTR) is a buy following the company's better-than-expected financial results, Jim Cramer said Friday on CNBC's "Squawk Box."

TWTR

EMA Starts Review Of Sanofi-GlaxoSmithKline’s COVID-19 Vaccine

By Vandana Singh

March 30, 3:24 PM

The European Medicines Agency has started reviewing Sanofi SA (NASDAQ:SNY) and its partner GlaxoSmithKline Plc’s (NYSE:GSK) application seeking conditional authorization for their…

GSK

News

The Lockwood Group Reports Strategic Investment Made By Fund Managed By Private Equity Group Of Ares Mgmt., No Terms Disclosed

By Benzinga Newsdesk

October 12, 4:23 PM

The Lockwood Group ("Lockwood"), an industry leader in scientific-based medical communications for the pharmaceutical, biotech, and medical device industries, announced today a strategic investment made by a

ARES

Maxim Group Initiates Coverage On Society Pass with Buy Rating, Announces Price Target of $9

By Benzinga Newsdesk

February 24, 10:01 AM

Maxim Group analyst Allen Klee initiates coverage on Society Pass (NASDAQ:SOPA) with a Buy rating and announces Price Target of $9.

SOPA

TESLARATI Tweet: Tesla FSD Beta 10.1 would be capable of reversing maneuvers

Related Posts

Jim Cramer Cheers Twitter, CFO Ned Segal Following Earnings

EMA Starts Review Of Sanofi-GlaxoSmithKline’s COVID-19 Vaccine

The Lockwood Group Reports Strategic Investment Made By Fund Managed By Private Equity Group Of Ares Mgmt., No Terms Disclosed

Maxim Group Initiates Coverage On Society Pass with Buy Rating, Announces Price Target of $9